Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Diltiazem Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic’s Generics Diltiazem HCl Receives Approval in US
    Alembic’s Generics Diltiazem HCl Receives Approval in US

    14 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217633

    FDA
    14 Nov 2025
    Share Share
    Zydus Gets USFDA Approval for Diltiazem Hydrochloride Tablets
    Zydus Gets USFDA Approval for Diltiazem Hydrochloride Tablets

    11 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/zydus-receives-final-approval-from-usfda-for-diltiazem-hydrochloride-tablets-usp-17578

    INDPHARMAPOST
    11 Aug 2025
    Share Share
    Zydus`s Generics Diltiazem Hydrochloride Receives Approval in US
    Zydus`s Generics Diltiazem Hydrochloride Receives Approval in US

    08 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219253

    FDA
    08 Aug 2025
    Share Share
    Novast’s Generics Diltiazem Hydrochloride Approved in US
    Novast’s Generics Diltiazem Hydrochloride Approved in US

    02 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218032

    FDA
    02 Jul 2025
    Share Share
    AMTA`s Generics Diltiazem HCl Receives Approval in US
    AMTA`s Generics Diltiazem HCl Receives Approval in US

    24 Mar 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219073

    FDA
    24 Mar 2025
    Share Share
    Enforcement Report - Week of December 11, 2024
    Enforcement Report - Week of December 11, 2024

    11 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2024-90405.pdf

    FDA
    11 Dec 2024
    Share Share